Fig. 2
From: Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells
Inhibition of oral cancer cell (SAS, SCC25, and OEC-M1) growth in vitro via the Danshen crude. The antioral cancer efficacy of the Danshen crude on three oral cancer cell lines (SAS, SCC25, and OEC-M1) treated for 24 h. The extract significantly reduced the cell viability of all three OSCC lines in a dose-dependent manner